Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades

Annals of Saudi Medicine

Volumn 23, Issue 6, 2003, Pages 367-371

  Al Faleh, Faleh Zaid ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NONE   (Saudi Arabia)

Author keywords

Epidemiology; Hepatitis A; Hepatitis B; Hepatitis C; Saudi Arabia

Indexed keywords

HEPATITIS B VACCINE;

ADULT; BLOOD DONOR; CONTROLLED STUDY; DATA ANALYSIS; ECONOMIC ASPECT; EDUCATION; ENDEMIC DISEASE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNIZATION; INFECTION RATE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MEDLINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; SCREENING TEST;

EID: 0348161558     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.367     Document Type: Review

References (29)

1. WHO Facts Sheet, WHO/204, Revised October 2000, Medline.
2. Laurer and Walker. Hepatitis C Virus Infection. N Eng J Med. 2001;315:41-52.
3. Global Surveillance and control of hepatitis C: A report of a WHO consultant Org. in collaboration with the viral hepatitis prevention, Board Antwerp, Belgium. J Viral Hepatitis. 1996;6:35-47.
4. Al-Faleh F. Hepatitis B infection in Saudi Arabia - Clinical Review. Ann Saudi Med. 1988;8(6):474-480.
5. Arya SC, Ashraf SJ, Parande CM, et al. Hepatitis B virus in Jizan, Saudi Arabia. J Med Virol. 1985;17:267-274.
6. Parande CM, Arya SC, Ashraf SJ. Hepatitis B virus among Saudi children in Jizan, Saudi Arabia. Infection. 1986;14:233-235.
7. Al-Faleh FZ, Ayoola A, Arif M, et al. Seroepidemiology of hepatitis B virus infection in Saudi children : A baseline survey for a mass vaccination against hepatitis B J Infect. 1992;24:197-206.
8. Al-Faleh FZ, Ayoola A, Al-Jeffry M, Arif M, Al-Rahsed R, Ramia S. Integration of hepatitis B vaccine into the expanded program on immunization: the Saudi Arabian experience. Ann Saudi Med 1993;13:231-236.
9. Al-Faleh FZ, Al-Jeffri M, Ramia S, Al-Rashed R, Arif M, Rezeig M, Al-Toraif I, Bakhsh M, Mishkhas A, Makki O, Al-Freihi H, Mirdad S, Aljumah AR, Yasin T, Al-Swailem AM, Ayoola A. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect. 1999;38:167-170.
10. Shobokshi O. Overview of viral hepatitis B through ii Virus (Abstract): the sixth Saudi Gastroenterology Meeting, 20 Nov. 1999.
11. Al-Faleh FZ, Ayoola EA, Al-Jeffry M, et al. Prevalence of antibody to hepatitis C virus among Arabian children : A community-based study. Hepatology. 1991;14:215-218.
12. Al-Faleh FZ, Ramia S, Arif M, Ayoola EA, Al-Rashed RS, Al-Jeffry M, Hussain A, Al-Hazmi M. Profile of hepatitis C virus (HCV) and the possible modes of transmission of the virus in Jizan area, Kingdom of Saudi Arabia - A community-based study. Ann Trop & Parasitol. 1995;89(4);431-437.
13. El-Hazmi MAF, Al-Faleh FZ, Warsy AS. Epidemiology of viral hepatitis among Saudi population. A study of viral markers in Khaiber. Saudi Med J. 1986;7(2):122-129.
14. Al-Rashed R. Prevalence of hepatitis A virus among Saudi Arabian children: A community-based study. Ann Saudi Med. 1997;17:200-203.
15. Al-Faleh FZ et al. Hepatitis A in Saudi Arabia: A comparative sero-epidemiological study. Saudi Med J. 1999;20(9):678-681.
16. Arif M, Al-Faleh FZ, Al-Frayh AR, Ramia S. Reduction in the prevalence of antibody to hepatitis A virus among young Saudi adults: Implications for hepatitis A vaccine. Saudi Med Gastroenterol. 1995;1:93-96.
17. Thomas DL, et al. The natural history of hepatitis C virus infection, host viral, environmental factors. JAMA. 2000;284:450-456.
18. Leonard B, Seefat QL. Long term mortality and morbidity of transmission Non-A and Non-B and type C hepatitis: A National Heart, Lung and Blood Institute Collaborative Study. Hepatology. 2001;33:455-463.
19. Stroffoline T et al. The impact of the hepatitis B mass community campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol.2000;32(6):980-985.
20. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS. Seroepidemiology of hepatitis B virus infection in children: ten years after mass vaccination in Taiwan. JAMA Middle East. 1996;276:906-908.
21. Horng KAO, et al. Low incidence of hepatitis C virus transmission between spouses: A prospective study. J Gastroenterol. 2000;15:391-395.
22. Davies et al. Prevalence of clinical course of hepatitis C virus infection and rate of HCV vertical transmission in cohort of 12 250 pregnant women.
23. Arif M, Al-Swayeh M, Al-Faleh FZ, Ramia S. Risk of hepatitis C virus infection among household contacts of Saudi patients with chronic liver disease. J Viral Hepatitis. 1996;3:97-101.
24. Ananyadas. An economic analysis of different strategies of immunization against hepatitis A virus in developed countires. Hepatology. 1999;29:548-552.
25. Armstrong GL, et al. The past incidence of hepatitis C virus infection. Implication for the future burden of chronic liver disease in the United States. Hepatology. 2000;313:777-782.
26. Harris et al. Clinical course of hepatitis C virus during the first decade of infection, cohort study. BMH. 2002;324:450.
27. Rodger et al. Assessment of long-term outcomes of community-oriented hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology. 32(3):82-87
28. Chany et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Eng J Med. 1997;336:1855-1859.
29. Alter M. Acute viral hepatitis in the United States, October 27-28, 2000. AASLD Postgraduate Course, Dallas, USA.